Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli

BACKGROUND: Ciprofloxacin, a fluoroquinolone, targets two essential bacterial enzymes, DNA gyrase and topoisomerase IV. Plasmid-borne qnr genes, encoding proteins that protect DNA gyrase and topoisomerase IV from inhibition by fluoroquinolones, contribute to resistance development. However, the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Garoff, Linnéa, Yadav, Kavita, Hughes, Diarmaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890660/
https://www.ncbi.nlm.nih.gov/pubmed/29106520
http://dx.doi.org/10.1093/jac/dkx375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890660/
https://www.ncbi.nlm.nih.gov/pubmed/29106520
http://dx.doi.org/10.1093/jac/dkx375

Ejemplares similares